News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Actavis Names Claudio Albrecht New Chief Executive
June 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES NEWSWIRES -- Icelandic generic drug maker Actavis Group (ACT-IC) Wednesday named Claudio Albrecht as new chief executive, succeeding Sigurdur Oli Olafsson, who is stepping down after working for the company for seven years.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Funding
Moonwalk pulls in $70M to take fat-targeting RNAi obesity candidate to clinic
September 8, 2026
·
2 min read
·
Michael Gibney
Funding
BrainChild Bio targets deadly pediatric brain cancer with $116M series A
September 8, 2026
·
2 min read
·
Tristan Manalac
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
·
5 min read
·
Angela Gabriel
Layoff Tracker
TScan axes 75% of workforce, prioritizes solid tumor program
September 7, 2026
·
90 min read
·
BioSpace Editorial Staff